Global Chronic Pain Treatment Market Analysis 2026–2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Chronic Pain Treatment Market At The End Of The 2026–2030 Forecast Period?

The chronic pain treatment market has experienced robust growth in recent years. This market is projected to expand from $109.05 billion in 2025 to reach $119.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Factors contributing to its historical expansion include opioid usage, musculoskeletal disorders, an aging population, the presence of hospital pain clinics, and effective post-surgical pain management.

The chronic pain treatment market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $168.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This projected growth can be attributed to factors such as opioid regulation, the emergence of device-based therapies, the increasing prevalence of chronic diseases, the integration of mental health services, and the rise of outpatient pain care. Key trends for the forecast period include a shift towards non-opioid pain therapies, the expansion of neuromodulation devices, a broadening of multidisciplinary pain management approaches, an increased emphasis on personalized pain care, and the incorporation of psychological support therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Primary Drivers Are Shaping The Development Of The Chronic Pain Treatment Market?

The escalating occurrence of arthritis pain is projected to drive the expansion of the chronic pain treatment market. Arthritis pain describes the discomfort, aching, or tenderness experienced in the joints due to inflammation or degeneration caused by arthritis. The increasing prevalence of arthritis pain primarily stems from the aging demographic, as natural wear and tear on joints intensifies with age, contributing to a higher incidence of arthritis-related conditions. Chronic pain treatment aids in managing arthritis pain by targeting inflammation and nerve sensitivity, which helps to alleviate discomfort, enhance joint function, and boost the overall quality of life for individuals grappling with persistent arthritis symptoms. For instance, in July 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis pain is propelling the growth of the chronic pain treatment market.

What Segment Types Make Up The Chronic Pain Treatment Market?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

Which Market Trends Are Creating New Opportunities In The Chronic Pain Treatment Market?

Leading companies in the chronic pain treatment market are concentrating on developing innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems. This focus aims to address the increasing demand for advanced non-opioid therapies, superior long-term pain management, and an improved quality of life for patients. Closed-loop SCS systems are implantable, rechargeable neurostimulators that continuously detect neural signals and automatically modify electrical stimulation in real time, unlike conventional open-loop SCS devices that deliver preset and non-responsive output. For example, in April 2024, Medtronic plc, an Ireland-based medical device company, obtained U.S. Food and Drug Administration (FDA) approval for its Inceptiv Neurostimulation System. This device is a compact, rechargeable implant that utilizes sensing electrodes to monitor evoked neural responses and automatically adjust stimulation. It provides full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. The system is engineered to offer more consistent pain relief, better responder outcomes, and enhanced comfort compared to traditional fixed-output SCS systems.

Who Are The Key Players Driving Competition In The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Read the full chronic pain treatment market report here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

How Does The Chronic Pain Treatment Market Perform Across Major Global Regions?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chronic Pain Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795